Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview

Nordic NE Tumour Group, Kjell Oberg*, Lone Astrup, Barbro Eriksson, Sture E. Falkmer, Ursula G. Falkmer, Jens Gustafsen, Caj Haglund, Ulrich Knigge, Morten H. Vatn, Matti Välimäki

*Corresponding author for this work

Research output: Contribution to journalJournal articleCommunication

111 Citations (Scopus)

Abstract

The incidence of neuroendocrine tumours of the gastroenteropancreatic system seems to have increased during the past decade. New diagnostic and therapeutic procedures have aroused the interest of physicians, though most see very few cases of such diseases. A group of members of the Nordic Neuroendocrine Tumour Group decided to compile some guidelines to facilitate the diagnosis and treatment of patients with these tumours. Part I of these guidelines discusses the principles of histopathology, biochemical and radiological diagnosis as well as therapeutic options.

Original languageEnglish
JournalActa Oncologica
Volume43
Issue number7
Pages (from-to)617-625
Number of pages9
ISSN0284-186X
DOIs
Publication statusPublished - 2004
Externally publishedYes

Keywords

  • Antineoplastic Agents/adverse effects
  • Gastrointestinal Neoplasms/diagnosis
  • Humans
  • Lung Neoplasms/diagnosis
  • Neuroendocrine Tumors/diagnosis
  • Pancreatic Neoplasms/diagnosis
  • Thymus Neoplasms/diagnosis

Fingerprint

Dive into the research topics of 'Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview'. Together they form a unique fingerprint.

Cite this